Maastricht University (MU) was founded in 1983 and has been ranked in 2018 the 5th best young university in the world (Times Higher Education '200 Under 50'). MU is the most international university in the Netherlands and, with 16,300 students and 4,300 employees, is still growing. The university stands out for its innovative education model, international character and multidisciplinary approach to research and education.

MERLN Institute for Technology-Inspired Regenerative Medicine was established in 2014 as part of the Maastricht University Medical Center (Maastricht UMC+) and MU where it maintains a leading position in the field of biomedical engineering, tissue engineering and regenerative medicine. The MERLN institute is composed of three departments that conduct research and training with an interdisciplinary group of principal investigators that focus their research at the interface between technology and biology. The MERLN institute has state-of-the art laboratories including biofabrication, microfluidics, chemistry, polymers, material, microscopy, clean room (ISO 5 -7), three ML-II tissue culture and wetlab equipped with high-end equipment. The MERLN institute has also high-performance computational infrastructures, data management and analysis.

 

 

 

Dr. Carlos Mota

Maastricht University       

E-Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Prof. Dr. Lorenzo Moroni

Maastricht University

E-Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.


                                              

                        

 

 

This project is funded under the frame of EuroNanoMed III
© 2018 4NanoEARDRM. All Rights Reserved.
Free Joomla! templates by Engine Templates

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.